•
Jun 30, 2018

REGENXBIO Q2 2018 Earnings Report

Total Revenue
$40M
Previous year: $6.56M
+510.0%
EPS
$0.3
Previous year: -$0.47
-163.8%
Gross Profit
$36.2M
Previous year: $5.25M
+589.4%
Cash and Equivalents
$107M
Previous year: $57.6M
+85.4%
Free Cash Flow
$67.5M
Previous year: -$28.7M
-335.2%
Total Assets
$336M
Previous year: $224M
+49.7%

REGENXBIO

REGENXBIO